Journal article

IL-6-driven STAT signalling in circulating CD4 lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis

Amy E Anderson, Arthur G Pratt, Mamdouh AK Sedhom, John Paul Doran, Christine Routledge, Ben Hargreaves, Philip M Brown, Kim-Anh Le Cao, John D Isaacs, Ranjeny Thomas

Annals of the Rheumatic Diseases | BMJ PUBLISHING GROUP | Published : 2016

University of Melbourne Researchers


Awarded by NHMRC

Awarded by Academy of Medical Sciences (AMS)

Awarded by Medical Research Council

Awarded by National Institute for Health Research

Awarded by NIHR Newcastle Biomedical Research Centre

Funding Acknowledgements

Pfizer, the Academy of Medical Sciences, NIHR Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals Foundation Trust & Newcastle University; NHMRC grants 1027657 and 569938; ARC Future Fellowship. The views expressed are those of the authors and not necessarily those of Pfizer, the NHS, the NIHR or the Department of Health.